Pain prevention drug trial for breast cancer patients halted early
NCT ID NCT03216187
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 24 times
Summary
This study looked at whether the drug pregabalin could prevent persistent pain in women at high risk after breast cancer surgery. About 126 participants were planned, but the trial was stopped early. The goal was to see if fewer people would have significant pain three months after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT POSTOPERATIVE PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brustzentrum Bern
Bern, Switzerland
-
Centre Hospitalier Universitaire Vaudois CHUV
Lausanne, 1011, Switzerland
-
Clinique de Genolier
Genolier, 1272, Switzerland
-
Clinique des Grangettes
Geneva, Switzerland
-
Hôpitaux Universitaires de Genève HUG
Geneva, 1211, Switzerland
-
Inselspital
Bern, 3010, Switzerland
Conditions
Explore the condition pages connected to this study.